Viral Clearance with Viresolve® Pro Solution: Prefiltration Strategies for Optimizing Performance
WEBINAR
Having challenges optimizing your virus clearance filter capacity and flux? Watch this webinar to learn how prefiltration technologies can provide significant increases in the performance of your viral clearance filter.
Size-exclusion-based filtration provides critical viral clearance assurance in biopharmaceutical production processes. Although process intermediates are highly purified prior to viral clearance filtration, the presence of protein aggregates, denatured proteins, and other trace fouling species can negatively impact the hydraulic performance of virus filters, increasing the required filtration area. Implementing a robust prefiltration step will clear these fouling species, leading to significant improvements in virus filter capacity, flux and an overall decrease in viral filtration costs.
In this webinar, you will learn:
- How feed aggregates and other impurities can negatively impact virus filter performance
- How prefiltration strategies can effectively and significantly increase virus filter capacity and flux while reducing costs
- How to select the best prefiltration technology for your given bioprocess
Speaker

Ben Cacace
Merck
Senior R&D Engineer
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
期间:50min
语言:English
场次 1:往期 September 20, 2018
如要继续阅读,请登录或创建帐户。
暂无帐户?